Company intelligence / Profile preview

Molecular Cloning Laboratories

South San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Molecular Cloning Laboratories (MCLAB) specializes in providing genomic research consumables, reagents, and contract research services for life science research, with a focus on DNA sequencing, molecular cloning, protein purification, next-generation sequencing (NGS), and a broad range of molecular biology products. The company does not develop or commercialize its own therapeutic candidates, has no active clinical trials listed, and serves the research, diagnostics, and biopharmaceutical communities as a supplier and service provider rather than a drug developer.

Modalities: AntibodyCRISPR-based therapyDNAEnzymePCR technologyProteinRecombinant proteinRNASmall molecule
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Molecular Cloning Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Molecular Cloning Laboratories.

Explore the full profile